Early Breast Cancer in Combination with An Aromatase Inhibitor for Adjuvant Treatment of Patients with Hormone Receptor-positive, Her2-negative Early Breast Cancer At High Risk of Recurrence

Early Breast Cancer in Combination with An Aromatase Inhibitor for Adjuvant Treatment of Patients with Hormone Receptor-positive, Her2-negative Early Breast Cancer At High Risk of Recurrence is a serious health matter that can affect many aspects of life. The medicines listed here including Ribociclib represent options that a clinician may discuss. Products containing Ribociclib feature in this group.